How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer.

Cognitive Dysfunction / diagnosis Humans Neoplasms / complications
Animal model Behavior Cancer patients Cancer treatments Cognition Electronic cognitive tests Management of cognitive impairment

Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 06 2019
revised: 18 09 2019
accepted: 19 09 2019
pubmed: 26 9 2019
medline: 29 7 2020
entrez: 26 9 2019
Statut: ppublish

Résumé

A number of neurotoxicity associated with oncological treatments has been reported in non-central nervous system cancers. An expert group presents the state of the art and a guide to help the choice of appropriated tools to assess patient cognition in studies on oncology and neurobehavior in animal models. In addition, current cognitive rehabilitation programs currently under evaluation are also discussed. Cognitive assessments in oncology depend on the research question, study design, cognitive domains, patients' characteristics, psychometric properties of the tests, and whether the tests are supervised or not by a neuropsychologist. Batteries of electronic tests can be proposed, but several of them are characterized by weak psychometric developments. In order to improve the comprehension on the impact of cancer treatments on cognition, new animal models are in development, and would in the future include non-human primate models. By bringing together the skills and practices of oncologists, neurologists, neuropsychologists, neuroscientists, we propose a series of specific tools and tests that accompany the cognitive management of non-CNS cancer patients.

Identifiants

DOI: 10.1016/j.neubiorev.2019.09.028 PMID: 31553925
pubmed: 31553925
pii: S0149-7634(19)30478-6
doi: 10.1016/j.neubiorev.2019.09.028
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

602-614

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Marie Lange (M)

Clinical Research Department, Centre François Baclesse, 14000 Caen, France; INSERM, U1086, ANTICIPE, 14000 Caen, France; Cancer & Cognition Platform, Ligue Contre le Cancer, 14000 Caen, France.

Hélène Castel (H)

Cancer & Cognition Platform, Ligue Contre le Cancer, 14000 Caen, France; Normandie Univ, UNIROUEN, INSERM, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France.

Johan Le Fel (J)

Care Support Department, Centre Henri-Becquerel, 76000 Rouen, France.

Laure Tron (L)

Cancer & Cognition Platform, Ligue Contre le Cancer, 14000 Caen, France; University Hospital of Caen, 1400 Caen, France.

Didier Maillet (D)

Neurology Department, Hôpital Saint Louis, 75000 Paris, France; Laboratoire PSITEC, EA 4072, UFR de Psychologie, Université de Lille, 59000 Villeneuve d'Ascq, France.

Myriam Bernaudin (M)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, 14000 Caen, France.

Omar Touzani (O)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, 14000 Caen, France.

Joy Perrier (J)

Normandie Univ, UNICAEN, PSL Research University, EPHE, INSERM, U1077, CHU de Caen, Neuropsychologie et Imagerie de la Mémoire Humaine, 14000 Caen, France.

Mathieu Boone (M)

Medical Oncology Department, University Hospital, 80000 Amiens, France.

Idlir Licaj (I)

INSERM, U1086, ANTICIPE, 14000 Caen, France; Cancer & Cognition Platform, Ligue Contre le Cancer, 14000 Caen, France.

Bénédicte Giffard (B)

Cancer & Cognition Platform, Ligue Contre le Cancer, 14000 Caen, France; Normandie Univ, UNICAEN, PSL Research University, EPHE, INSERM, U1077, CHU de Caen, Neuropsychologie et Imagerie de la Mémoire Humaine, 14000 Caen, France.

Martine Dubois (M)

Normandie Univ, UNIROUEN, INSERM, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France.

Olivier Rigal (O)

Care Support Department, Centre Henri-Becquerel, 76000 Rouen, France; Medical Oncology Department, Centre Henri-Becquerel, 76000 Rouen, France.

Thomas Durand (T)

UMR MD4 8257 CNRS, University of Paris Descartes, SSA, 75006 Paris, France.

Catherine Belin (C)

Neurology Department, Hôpital Saint Louis, 75000 Paris, France.

Damien Ricard (D)

UMR MD4 8257 CNRS, University of Paris Descartes, SSA, 75006 Paris, France.

Rozenn Le Gal (R)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, 14000 Caen, France.

Véronique Pancré (V)

Cancéropôle Nord-Ouest, 59000 Lille, France.

Isabelle Hardy-Léger (I)

NeuroHIV Rehabilitation Unit, CHU de Bicêtre, APHP, 94275 Le Kremlin Bicêtre, France.

Florence Joly (F)

Clinical Research Department, Centre François Baclesse, 14000 Caen, France; INSERM, U1086, ANTICIPE, 14000 Caen, France; Cancer & Cognition Platform, Ligue Contre le Cancer, 14000 Caen, France; Medical Oncology Department, CHU de Caen, 14000 Caen, France. Electronic address: f.joly@baclesse.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Troubles de la cognition › Dysfonctionnement cognitif › How to assess and manage cognitive impairment...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › How to assess and manage cognitive impairment...
questionsmedicales.fr › Tumeurs › How to assess and manage cognitive impairment...